34. Uncommon indications for brachytherapy - The GEC-ESTRO Handbook of Brachytherapy

Uncommon indications for brachytherapy

10

THE GEC ESTRO HANDBOOK OF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 30/04/2025

7. REFERENCES

1. National comprehensive cancer network. Practice Guidelines in Oncology 2023. 2. Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee J, Boye K, Brennan B, Brodowicz T, Buonadonna A, De Alava E, Del Muro XG, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F, Grignani G, Haas R, Hassan AB, Hecker-Nolting S, Hindi N, Hohenberger P, Joensuu H, Jones RL, Jungels C, Jutte P, Kager L, Kasper B, Kawai A, Kopeckova K, Krakorova DA, Le Cesne A, Le Grange F, Legius E, Leithner A, Lopez-Pousa A, Martin-Broto J, Merimsky O, Messiou C, Mir O, Montemurro M, Morland B, Morosi C, Palmerini E, Pantaleo MA, Piana R, Piperno-Neumann S, Reichardt P, Rutkowski P, Safwat AA, Sangalli C, Sbaraglia M, Scheipl S, Schoffski P, Sleijfer S, Strauss D, Strauss S, Sundby Hall K, Trama A, Unk M, van de Sande MAJ, van der Graaf WTA, van Houdt WJ, Frebourg T, Casali PG, Stacchiotti S, Esmo Guidelines Committee E, clinicalguidelines@esmo.org GEa. Soft tissue and visceral sarcomas: Esmo euracan-genturis clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021;32:1348-1365. 3. Penel N, Grosjean J, Robin YM, Vanseymortier L, Clisant S, Adenis A. Frequency of certain established risk factors in soft tissue sarcomas in adults: A prospective descriptive study of 658 cases. Sarcoma 2008;2008:459386. 4. Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, Demoss EV, Seipp C, Sindelar WF, Sugarbaker P, Wesley R. The treatment of soft-tissue sarcomas of the extremities: Prospective randomized evaluations of (1) limb sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. AnnSurg 1982;196:305-315. 5. Harrison LB, Franzese F, Gaynor JJ, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 1993;27:259-265. 6. Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ, Rosenberg SA. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. JClinOncol 1998;16:197-203. 7. O'Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, Pater J, Zee B. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet 2002;359:2235-2241. 8. Davis AM, O'Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Hammond A, Benk V, Kandel R, Goddard K, Freeman C, Sadura A, Zee B, Day A, Tu D, Pater J. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 2005;75:48-53. 9. Alekhteyar KM, Leung DH, Brennan MF, Harrison LB. The effect of combined external beam radiotherapy and brachytherapy on local control and wound complications in patients with high-grade soft tissue sarcomas of the extremity with positive microscopic margin. Int J Radiat Oncol Biol Phys 1996;36:321-324. 10. Cahlon O, Brennan MF, Jia X, Qin LX, Singer S, Alektiar KM. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Ann Surg 2012;255:343-347. 11. Zelefsky MJ, Nori D, Shiu MH, Brennan MF. Limb salvage in soft tissue sarcomas involving neurovascular structures using combined surgical resection and brachytherapy. Int J Radiat Oncol Biol Phys 1990;19:913-918. 12. Andrews SF, Anderson PR, Eisenberg BL, Hanlon AL, Pollack A. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy. IntJRadiatOncolBiolPhys 2004;59:475-480. 13. Naghavi AO, Fernandez DC, Mesko N, Juloori A, Martinez A, Scott JG, Shah C, Harrison LB. American brachytherapy society consensus statement for soft tissue sarcoma brachytherapy. Brachytherapy 2017;16:466-489. 14. O'Sullivan B, Griffin AM, Dickie CI, Sharpe MB, Chung PW, Catton CN, Ferguson PC, Wunder JS, Deheshi BM, White LM, Kandel RA, Jaffray DA, Bell RS. Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma. Cancer 2013;119:1878-1884. 15. Wang D, Zhang Q, Eisenberg BL, Kane JM, Li XA, Lucas D, Petersen IA, DeLaney TF, Freeman CR, Finkelstein SE, Hitchcock YJ, Bedi M, Singh AK,

Dundas G, Kirsch DG. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: Results of radiation therapy oncology group rtog-0630 trial. J Clin Oncol 2015;33:2231-2238. 16. Haas RL, Delaney TF, O'Sullivan B, Keus RB, Le Pechoux C, Olmi P, Poulsen JP, Seddon B, Wang D. Radiotherapy for management of extremity soft tissue sarcomas: Why, when, and where? Int J Radiat Oncol Biol Phys 2012;84:572-580. 17. Alektiar KM, Leung D, Zelefsky MJ, Healey JH, Brennan MF. Adjuvant brachytherapy for primary high-grade soft tissue sarcoma of the extremity. Ann Surg Oncol 2002;9:48-56. 18. Emory CL, Montgomery CO, Potter BK, Keisch ME, Conway SA. Early complications of high-dose-rate brachytherapy in soft tissue sarcoma: A comparison with traditional external-beam radiotherapy. Clin OrthopRelat Res 2012;470:751-758. 19. Itami J, Sumi M, Beppu Y, Chuman H, Kawai A, Murakami N, Morota M, Mayahara H, Yoshimura R, Ito Y, Kagami Y. High-dose rate brachytherapy alone in postoperative soft tissue sarcomas with close or positive margins. Brachytherapy 2010;9:349-353. 20. Campbell SR, Shah C, Scott JG, Mesko N, Nystrom L, Kolar M, Largo AC, Kamrava M, Mourtada F, Naghavi AO, Harrison LB. American brachytherapy society (abs) consensus statement for soft-tissue sarcoma brachytherapy. Brachytherapy 2021;20:1200-1218. 21. Cortesi A, Galuppi A, Frakulli R, Arcelli A, Romani F, Mattiucci GC, Bianchi G, Ferrari S, Ferraro A, Farioli A, Gambarotti M, Righi A, Macchia G, Deodato F, Cilla S, Buwenge M, Valentini V, Morganti AG, Donati D, Cammelli S. Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas. J Contemp Brachytherapy 2017;9:256-262. 22. Beltrami G, Rudiger HA, Mela MM, Scoccianti G, Livi L, Franchi A, Campanacci DA, Capanna R. Limb salvage surgery in combination with brachytherapy and external beam radiation for high-grade soft tissue sarcomas. Eur J Surg Oncol 2008;34:811-816. 23. Llacer C, Delannes M, Minsat M, Stoeckle E, Votron L, Martel P, Bonnevialle P, Nguyen Bui B, Chevreau C, Kantor G, Daly-Schveitzer N, Thomas L. Low-dose intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structure. Radiother Oncol 2006;78:10-16. 24. Delannes M, Thomas L, Martel P, Bonnevialle P, Stoeckle E, Chevreau C, Bui BN, Daly-Schveitzer N, Pigneux J, Kantor G. Low-dose-rate intraoperative brachytherapy combined with external beam irradiation in the conservative treatment of soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2000;47:165-169. 25. Gimeno M, San Julián M, Cambeiro M, Arbea L, Jablonska P, Moreno-Jiménez M, Amillo S, Aristu J, Lecanda F, Martinez-Monge R. Long-term results of perioperative high dose rate brachytherapy (phdrb) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled trial. Radiother Oncol 2019;in press. 26. Alektiar KM, Zelefsky MJ, Brennan MF. Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 2000;47:1273-1279. 27. Ormsby MV, Hilaris BS, Nori D, Brennan MF. Wound complications of adjuvant radiation therapy in patients with soft-tissue sarcomas. AnnSurg 1989;210:93-99. 28. Gomez-Alvarez J, Martin Pastor S, Gimeno M, Lamo-Espinosa J, Ramos LI, Cambeiro M, Tagliaferri L, Kovacs G, Strnad V, San-Julian M, Martinez-Monge R. Dose volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative hdr brachytherapy. Radiother Oncol 2022;170:159-164. 29. Lin PP, Schupak KD, Boland PJ, Brennan MF, Healey JH. Pathologic femoral fracture after periosteal excision and radiation for the treatment of soft tissue sarcoma. Cancer 1998;82:2356-2365. 30. Kubo T, Sugita T, Shimose S, Matsuo T, Hirao K, Kimura H, Kenjo M, Ochi M. Nerve tolerance to high-dose-rate brachytherapy in patients with soft tissue sarcoma: A retrospective study. BMC Cancer 2005;5:79. 31. Indelicato DJ, Meadows K, Gibbs CP, Jr., Morris CG, Scarborough MT, Zlotecki RA. Effectiveness and morbidity associated with reirradiation in conservative salvage management of recurrent soft-tissue sarcoma. Int J RadiatOncol BiolPhys 2009;73:267-272.